Surmodics, Inc. (SRDX)
USD 30.11
(-2.11%)
USD 30.11
(-2.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 98.69 Million USD | 78.09% |
| 2023 | 55.42 Million USD | 8.46% |
| 2022 | 51.09 Million USD | 52.65% |
| 2021 | 33.47 Million USD | 9.35% |
| 2020 | 30.61 Million USD | 16.14% |
| 2019 | 26.35 Million USD | -0.93% |
| 2018 | 26.6 Million USD | 16.18% |
| 2017 | 22.89 Million USD | 12.12% |
| 2016 | 20.42 Million USD | 13.3% |
| 2015 | 18.02 Million USD | 17.83% |
| 2014 | 15.29 Million USD | 10.38% |
| 2013 | 13.85 Million USD | -50.8% |
| 2012 | 28.16 Million USD | -44.99% |
| 2011 | 51.2 Million USD | 40.79% |
| 2010 | 36.36 Million USD | -33.59% |
| 2009 | 54.76 Million USD | -10.69% |
| 2008 | 61.31 Million USD | 45.61% |
| 2007 | 42.1 Million USD | 38.87% |
| 2006 | 30.32 Million USD | 15.45% |
| 2005 | 26.26 Million USD | -27.51% |
| 2004 | 36.22 Million USD | 81.66% |
| 2003 | 19.94 Million USD | 23.9% |
| 2002 | 16.09 Million USD | 26.87% |
| 2001 | 12.68 Million USD | 3.44% |
| 2000 | 12.26 Million USD | 19.08% |
| 1999 | 10.3 Million USD | 24.1% |
| 1998 | 8.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 23.32 Million USD | 73.95% |
| 2024 Q3 | 26.39 Million USD | 13.16% |
| 2024 Q1 | 13.4 Million USD | -2.03% |
| 2023 Q1 | 14.15 Million USD | -4.02% |
| 2023 FY | 55.42 Million USD | 8.46% |
| 2023 Q3 | 13.75 Million USD | -0.61% |
| 2023 Q2 | 13.83 Million USD | -2.23% |
| 2023 Q4 | 13.68 Million USD | -0.49% |
| 2022 Q1 | 10.28 Million USD | 14.46% |
| 2022 Q2 | 12.18 Million USD | 18.51% |
| 2022 FY | 51.09 Million USD | 52.65% |
| 2022 Q3 | 13.87 Million USD | 13.9% |
| 2022 Q4 | 14.74 Million USD | 6.25% |
| 2021 FY | 33.47 Million USD | 9.35% |
| 2021 Q3 | 8.44 Million USD | -0.26% |
| 2021 Q2 | 8.46 Million USD | 11.72% |
| 2021 Q1 | 7.57 Million USD | -3.42% |
| 2021 Q4 | 8.98 Million USD | 6.36% |
| 2020 Q4 | 7.84 Million USD | -1.32% |
| 2020 Q1 | 7.53 Million USD | -3.15% |
| 2020 Q2 | 7.27 Million USD | -3.49% |
| 2020 FY | 30.61 Million USD | 16.14% |
| 2020 Q3 | 7.95 Million USD | 9.32% |
| 2019 Q3 | 6.53 Million USD | 19.31% |
| 2019 Q1 | 6.55 Million USD | -7.91% |
| 2019 Q2 | 5.48 Million USD | -16.4% |
| 2019 FY | 26.35 Million USD | -0.93% |
| 2019 Q4 | 7.78 Million USD | 19.03% |
| 2018 Q4 | 7.11 Million USD | 7.83% |
| 2018 FY | 26.6 Million USD | 16.18% |
| 2018 Q2 | 7.07 Million USD | 21.87% |
| 2018 Q1 | 5.8 Million USD | -2.19% |
| 2018 Q3 | 6.6 Million USD | -6.71% |
| 2017 FY | 22.89 Million USD | 12.12% |
| 2017 Q4 | 5.93 Million USD | 1.73% |
| 2017 Q3 | 5.83 Million USD | 2.96% |
| 2017 Q2 | 5.66 Million USD | 3.83% |
| 2017 Q1 | 5.45 Million USD | -0.64% |
| 2016 Q1 | 6.6 Million USD | 6.76% |
| 2016 Q3 | 5.28 Million USD | -6.11% |
| 2016 Q2 | 5.63 Million USD | -14.68% |
| 2016 Q4 | 5.49 Million USD | 3.86% |
| 2016 FY | 20.42 Million USD | 13.3% |
| 2015 Q3 | 4.02 Million USD | -2.47% |
| 2015 Q4 | 6.18 Million USD | 53.72% |
| 2015 Q1 | 3.69 Million USD | 3.71% |
| 2015 FY | 18.02 Million USD | 17.83% |
| 2015 Q2 | 4.12 Million USD | 11.7% |
| 2014 Q3 | 3.59 Million USD | -16.37% |
| 2014 Q1 | 3.85 Million USD | 66.93% |
| 2014 FY | 15.29 Million USD | 10.38% |
| 2014 Q2 | 4.29 Million USD | 11.5% |
| 2014 Q4 | 3.56 Million USD | -0.84% |
| 2013 Q3 | 4.05 Million USD | 5.33% |
| 2013 Q1 | 3.65 Million USD | -49.57% |
| 2013 Q4 | 2.3 Million USD | -43.07% |
| 2013 Q2 | 3.84 Million USD | 5.31% |
| 2013 FY | 13.85 Million USD | -50.8% |
| 2012 Q1 | 7.1 Million USD | -45.93% |
| 2012 FY | 28.16 Million USD | -44.99% |
| 2012 Q4 | 7.24 Million USD | 4.74% |
| 2012 Q3 | 6.91 Million USD | 0.13% |
| 2012 Q2 | 6.9 Million USD | -2.79% |
| 2011 FY | 51.2 Million USD | 40.79% |
| 2011 Q3 | 12.81 Million USD | -2.67% |
| 2011 Q2 | 13.16 Million USD | 9.03% |
| 2011 Q4 | 13.13 Million USD | 2.51% |
| 2011 Q1 | 12.07 Million USD | 31.37% |
| 2010 FY | 36.36 Million USD | -33.59% |
| 2010 Q3 | 13.8 Million USD | 2.62% |
| 2010 Q4 | 9.19 Million USD | -33.43% |
| 2010 Q2 | 13.45 Million USD | 6.33% |
| 2010 Q1 | 12.65 Million USD | -42.95% |
| 2009 Q3 | 3.91 Million USD | -11.2% |
| 2009 Q1 | 14.03 Million USD | -8.5% |
| 2009 Q2 | 4.4 Million USD | -68.63% |
| 2009 FY | 54.76 Million USD | -10.69% |
| 2009 Q4 | 22.18 Million USD | 467.34% |
| 2008 Q1 | 13.47 Million USD | -22.33% |
| 2008 FY | 61.31 Million USD | 45.61% |
| 2008 Q4 | 15.34 Million USD | 0.14% |
| 2008 Q3 | 15.31 Million USD | -6.43% |
| 2008 Q2 | 16.37 Million USD | 21.49% |
| 2007 Q1 | 7.54 Million USD | 1.3% |
| 2007 FY | 42.1 Million USD | 38.87% |
| 2007 Q4 | 17.35 Million USD | 92.21% |
| 2007 Q3 | 9.02 Million USD | 10.29% |
| 2007 Q2 | 8.18 Million USD | 8.48% |
| 2006 FY | 30.32 Million USD | 15.45% |
| 2006 Q1 | 7.2 Million USD | -19.79% |
| 2006 Q2 | 7.88 Million USD | 9.45% |
| 2006 Q3 | 7.78 Million USD | -1.27% |
| 2006 Q4 | 7.44 Million USD | -4.33% |
| 2005 FY | 26.26 Million USD | -27.51% |
| 2005 Q4 | 8.98 Million USD | 35.52% |
| 2005 Q3 | 6.62 Million USD | 13.36% |
| 2005 Q2 | 5.84 Million USD | 21.51% |
| 2005 Q1 | 4.81 Million USD | 8.38% |
| 2004 FY | 36.22 Million USD | 81.66% |
| 2004 Q4 | 4.43 Million USD | -79.28% |
| 2004 Q1 | 5.06 Million USD | -0.57% |
| 2004 Q2 | 5.3 Million USD | 4.82% |
| 2004 Q3 | 21.41 Million USD | 303.52% |
| 2003 Q3 | 5.27 Million USD | 6.26% |
| 2003 Q2 | 4.96 Million USD | 7.84% |
| 2003 Q1 | 4.6 Million USD | 5.5% |
| 2003 Q4 | 5.09 Million USD | -3.51% |
| 2003 FY | 19.94 Million USD | 23.9% |
| 2002 FY | 16.09 Million USD | 26.87% |
| 2002 Q4 | 4.36 Million USD | 8.61% |
| 2002 Q3 | 4.02 Million USD | -0.37% |
| 2002 Q2 | 4.03 Million USD | 9.8% |
| 2002 Q1 | 3.67 Million USD | 6.86% |
| 2001 Q1 | 3.26 Million USD | -3.72% |
| 2001 FY | 12.68 Million USD | 3.44% |
| 2001 Q4 | 3.43 Million USD | 6.7% |
| 2001 Q3 | 3.22 Million USD | -8.18% |
| 2001 Q2 | 3.51 Million USD | 7.57% |
| 2000 Q2 | 3.15 Million USD | 16.7% |
| 2000 Q1 | 2.7 Million USD | 58.82% |
| 2000 FY | 12.26 Million USD | 19.08% |
| 2000 Q4 | 3.38 Million USD | 13.84% |
| 2000 Q3 | 2.97 Million USD | -5.52% |
| 1999 Q1 | 2.6 Million USD | 13.04% |
| 1999 Q3 | 3.1 Million USD | 6.9% |
| 1999 Q2 | 2.9 Million USD | 11.54% |
| 1999 FY | 10.3 Million USD | 24.1% |
| 1999 Q4 | 1.7 Million USD | -45.16% |
| 1998 FY | 8.3 Million USD | 0.0% |
| 1998 Q4 | 2.3 Million USD | 0.0% |
| 1998 Q2 | 2.3 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | 2.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -779.339% |
| Cerus Corporation | 143.15 Million USD | 31.056% |
| OrthoPediatrics Corp. | 137.01 Million USD | 27.968% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -768.745% |
| Talis Biomedical Corporation | 67.18 Million USD | -46.901% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -295.643% |
| Inogen, Inc. | 236.08 Million USD | 58.194% |
| Spectral AI, Inc. | 20.86 Million USD | -373.049% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -76.254% |
| CVRx, Inc. | 76.14 Million USD | -29.622% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -2697.537% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -690.271% |
| Orthofix Medical Inc. | 667.42 Million USD | 85.212% |
| Venus Concept Inc. | 80.47 Million USD | -22.642% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -74.444% |
| Bioventus Inc. | 409.91 Million USD | 75.923% |
| BrainsWay Ltd. | 28.01 Million USD | -252.263% |
| Envoy Medical, Inc. | 17.89 Million USD | -451.442% |
| electroCore, Inc. | 32.03 Million USD | -208.13% |
| IceCure Medical Ltd | 16.87 Million USD | -484.836% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -132.6% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -459.728% |
| MaxCyte, Inc. | 84.84 Million USD | -16.326% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -695.189% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1607.16% |
| PAVmed Inc | 64.82 Million USD | -52.247% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -93.228% |
| RxSight, Inc. | 103.85 Million USD | 4.962% |
| Sight Sciences, Inc. | 126.44 Million USD | 21.947% |
| SI-BONE, Inc. | 156.35 Million USD | 36.875% |
| TELA Bio, Inc. | 84.18 Million USD | -17.235% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -40.883% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 51.468% |
| LivaNova PLC | 843.54 Million USD | 88.3% |
| 908 Devices Inc. | 68.08 Million USD | -44.972% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 79.591% |
| Nemaura Medical Inc. | 7.13 Million USD | -1282.543% |
| NeuroPace, Inc. | 75.29 Million USD | -31.079% |
| LENSAR, Inc. | 33.33 Million USD | -196.067% |
| Apyx Medical Corporation | 51.01 Million USD | -93.455% |
| Cutera, Inc. | 197.72 Million USD | 50.083% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -298.277% |
| BioSig Technologies, Inc. | 28.53 Million USD | -245.941% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 48.454% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -173.702% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 88.2% |
| Axonics, Inc. | 270.2 Million USD | 63.473% |
| Outset Medical, Inc. | 198.77 Million USD | 50.346% |
| IRIDEX Corporation | 31.81 Million USD | -210.231% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 45.235% |
| IRadimed Corporation | 30.12 Million USD | -227.649% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1056.786% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1156.759% |
| Telesis Bio, Inc. | 63.48 Million USD | -55.455% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -0.248% |
| Varex Imaging Corporation | 224.8 Million USD | 56.096% |
| Quipt Home Medical Corp. | 148.66 Million USD | 33.612% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -741.909% |
| Pulmonx Corporation | 112.68 Million USD | 12.415% |
| Dynatronics Corporation | 9.9 Million USD | -896.132% |
| Modular Medical, Inc. | 17.52 Million USD | -463.05% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -388.914% |
| Semler Scientific, Inc. | 38.94 Million USD | -153.433% |
| InMode Ltd. | 215.68 Million USD | 54.239% |
| Bruker Corporation | 1.07 Billion USD | 90.831% |
| Cytosorbents Corporation | 48.33 Million USD | -104.186% |
| DexCom, Inc. | 1.69 Billion USD | 94.164% |
| Align Technology, Inc. | 2.07 Billion USD | 95.248% |
| Viveve Medical, Inc. | 22.17 Million USD | -345.122% |
| ZimVie Inc. | 275.12 Million USD | 64.127% |
| Movano Inc. | 29.69 Million USD | -232.425% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 28.101% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1607.16% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -2697.537% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 83.576% |
| Profound Medical Corp. | 33.6 Million USD | -193.714% |
| Insulet Corporation | 939.9 Million USD | 89.499% |
| enVVeno Medical Corporation | 25.23 Million USD | -291.065% |
| iCAD, Inc. | 22.22 Million USD | -344.081% |
| Nuwellis, Inc. | 22.61 Million USD | -336.461% |
| Biotricity, Inc. | 17.18 Million USD | -474.336% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 77.865% |
| Aethlon Medical, Inc. | 12.27 Million USD | -703.884% |
| InspireMD, Inc. | 22.95 Million USD | -330.052% |
| PAVmed Inc. | 64.82 Million USD | -52.247% |
| BIOLASE, Inc. | 34.66 Million USD | -184.749% |
| Beyond Air, Inc. | 61.7 Million USD | -59.963% |
| FONAR Corporation | 28.6 Million USD | -245.038% |
| AxoGen, Inc. | 149.33 Million USD | 33.909% |
| Vivani Medical, Inc. | 26.96 Million USD | -266.019% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 44.268% |
| Inari Medical, Inc. | 448.59 Million USD | 77.999% |
| UFP Technologies, Inc. | 58.08 Million USD | -69.907% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1902.943% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -1462.084% |
| Tenon Medical, Inc. | 16.96 Million USD | -481.665% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1235.006% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -123.788% |
| AdaptHealth Corp. | 1.07 Billion USD | 90.844% |
| Sintx Technologies, Inc. | 15.2 Million USD | -549.28% |
| NanoVibronix, Inc. | 4.97 Million USD | -1884.657% |
| Quanterix Corporation | 118.1 Million USD | 16.429% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -741.909% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -583.403% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 74.865% |
| TransMedics Group, Inc. | 182.82 Million USD | 46.014% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -251.673% |
| NeuroMetrix, Inc. | 11.09 Million USD | -789.248% |
| Hyperfine, Inc. | 52.87 Million USD | -86.672% |
| Establishment Labs Holdings Inc. | 172 Million USD | 42.619% |
| Biomerica, Inc. | 6.97 Million USD | -1314.402% |
| Bone Biologics Corporation | 9.42 Million USD | -946.816% |
| AVITA Medical, Inc. | 80.77 Million USD | -22.181% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -857.181% |
| Silk Road Medical, Inc | 186.35 Million USD | 47.039% |